Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer Institute researchers unexpectedly finds that estrogens play a role in fueling ...
The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.
I heard everything he said, but I can’t remember anything he said. I remember that he cried, but also that he laughed. He wore his emotions like a second skin, and despite his difficult life his def ...
The General Assembly will not hold a special meeting to override Gov. John Carney's veto of House Bill 140, the end-of-life ...
The hormone decreases a type of white blood cell that helps keep tumors in check; restricting the hormone could be a ...
By way of two resoundingly consistent votes, members of an FDA advisory committee agreed that PD-1 inhibitors do not have a favorable risk/benefit profile for gastroesophageal cancers with low PD-L1 ...
Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer ...
Over 54 pages, the report paints a picture of a VA Western New York Healthcare System where local system administrators ...
His book, “American Ramble,” lyrically recounted a 330-mile trek from Washington, D.C., to New York City while he was in ...
Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer ...
A recent report by the American Association for Cancer Research suggests adding cancer-specific warning labels to alcoholic ...
New data show Talvey’s potential in multiple myeloma drug combinations. Elsewhere, AbbVie got more positive Parkinson’s drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback